Anti-atherogenic effect of chromium picolinate in streptozotocin-induced experimental diabetes

Journal of Diabetes

Volumn 5, Issue 1, 2013, Pages 43-50

  Sundaram, Bhuvaneshwari ^a   Singhal, Kirti ^a   Sandhir, Rajat ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Cholesterol; Chromium; Diabetes; Lipids; Triglycerides

Indexed keywords

CHROMIUM PICOLINATE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA DAMAGE; DRUG EFFECT; HYPERTRIGLYCERIDEMIA; LIPOGENESIS; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RISK FACTOR; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ATHEROSCLEROSIS; CHOLESTEROL; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSEPHOSPHATE DEHYDROGENASE; MALE; PICOLINIC ACIDS; RATS; RATS, WISTAR; RISK FACTORS; STREPTOZOCIN; TRIGLYCERIDES;

EID: 84873468254     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/j.1753-0407.2012.00211.x     Document Type: Article

References (71)

1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010; 87: 4-14.
2. Standl E, Balletshofer B, Dahl B et al.Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: The Munich General Practitioner Project. Diabetologia. 1996; 39: 1540-5.
3. Friesinger GC 2nd, Gavin JA 3rd. Diabetes and the cardiologists: A call to action. J Am Coll Cardiol. 2000; 35: 1130-3.
4. Hammoud T, Tanguay JF, Bourassa MG. Management of coronary artery disease: Therapeutic options in patients with diabetes. J Am Coll Cardiol. 2000; 36: 355-65.
5. Carr ME. Diabetes mellitus: A hypercoagulable state. J Diabetes Complications. 2001; 15: 44-54.
6. Lee DN, Yen HT, Shen TF, Chen BJ. Chromium-induced glucose uptake, superoxide anion production, and phagocytosis in cultured pulmonary alveolar macrophages of weanling pigs. Biol Trace Elem Res. 2000; 77: 53-64.
7. DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am. 2004; 88: 787-835.
8. Del Prato S. Megatrials in type 2 diabetes. From excitement to frustration?Diabetologia. 2009; 52: 1219-26.
9. Zargar AH, Shah NA, Masoodi SR et al.Copper, zinc, and magnesium levels in non-insulin dependent diabetes mellitus. Postgrad Med J. 1998; 74: 665-8.
10. Pugazhenthi S, Khandelwal RL. Insulin-like effects of vanadate on hepatic glycogen metabolism in nondiabetic and streptozocin-induced diabetic rats. Diabetes. 1990; 39: 821-7.
11. Barbera A, Fernandez-Alvarez J, Truc A, Gomis R, Guinovart JJ. Effects of tungstate in neonatally streptozotocin-induced diabetic rats: Mechanism leading to normalization of glycaemia. Diabetologia. 1997; 40: 143-9.
12. Chen MD, Lin PY, Tsou CT, Wang JJ, Lin WH. Selected metals status in patients with noninsulin-dependent diabetes mellitus. Biol Trace Elem Res. 1995; 50: 119-24.
13. Vincent JB. Quest for the molecular mechanism of chromium action and its relationship to diabetes. Nutr Rev. 2000; 58: 67-72.
14. Schwarz K, Mertz W. Chromium(III) and the glucose tolerance factor. Arch Biochem Biophys. 1959; 85: 292-5.
15. Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A. Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr. 1977; 30: 531-8.
16. Davies S, McLaren Howard J, Hunnisett A, Howard M. Age-related decreases in chromium levels in 51665 hair, sweat, and serum samples from 40872 patients: Implications for the prevention of cardiovascular disease and type II diabetes mellitus. Metabolism. 1997; 46: 469-73.
17. Wang H, Kruszewski A, Brautigan DL. Cellular chromium enhances activation of insulin receptor kinase. Biochemistry. 2005; 44: 8167-75.
18. Sundaram B, Singhal K, Sandhir R. Ameliorating effect of chromium administration on hepatic glucose metabolism in streptozotocin-induced experimental diabetes. BioFactors. 2012; 38: 59-68.
19. Uusitupa MI, Kumpulainen JT, Voutilainen E et al.Effect of inorganic chromium supplementation on glucose tolerance, insulin response, and serum lipids in noninsulin-dependent diabetics. Am J Clin Nutr. 1983; 38: 404-10.
20. Racek J, Trefil L, Rajdl D, Mudrova V, Hunter D, Senft V. Influence of chromium-enriched yeast on blood glucose and insulin variables, blood lipids, and markers of oxidative stress in subjects with type 2 diabetes mellitus. Biol Trace Elem Res. 2006; 109: 215-30.
21. Li F, Wu X, Zou Y et al.Comparing anti-hyperglycemic activity and acute oral toxicity of three different trivalent chromium complexes in mice. Food Chem Toxicol. 2012; 50: 1623-31.
22. Berner TO, Murphy MM, Slesinski R. Determining the safety of chromium tripicolinate for addition to foods as a nutrient supplement. Food Chem Toxicol. 2004; 42: 1029-42.
23. Jeejeebhoy KN. The role of chromium in nutrition and therapeutics and as a potential toxin. Nutr Rev. 1999; 57: 329-35.
24. Cefalu WT, Hu FB. Role of chromium in human health and in diabetes. Diabetes Care. 2004; 27: 2741-51.
25. Pechova A, Pavlata L. Chromium as an essential nutrient: A review. Vet Med. 2007; 52: 1-18.
26. Sahin K, Onderci M, Tuzcu M et al.Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: The fat-fed, streptozotocin-treated rat. Metabolism. 2007; 56: 1233-40.
27. Price Evans DA, Tariq M, Dafterdar R, Al Hussaini H, Sobki SH. Chromium chloride administration causes a substantial reduction of coronary lipid deposits, aortic lipid deposits, and serum cholesterol concentration in rabbits. Biol Trace Elem Res. 2009; 130: 262-72.
28. Stearns DM, Armstrong WH. Mononuclear and binuclear chromium(III) picolinate complexes. Inorg Chem. 1992; 31: 6178-84.
29. Anderson RA, Cheng N, Bryden NA, Polansky MM, Chi J, Feng J. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes. 1997; 46: 1786-91.
30. Anderson RA, Bryden NA, Polansky MM. Lack of toxicity of chromium chloride and chromium picolinate in rats. J Am Coll Nutr. 1997; 16: 273-9.
31. Indian National Science Academy (INSA). Guidelines for Care and Use of Animals in Scientific Research. INSA, New Delhi, 2000.
32. Frings CS, Fendley TW, Dunn RT, Queen CA. Improved determination of total serum lipids by the sulfo-phospho-vanillin reaction. Clin Chem. 1972; 18: 673-4.
33. McGowan MW, Artiss JD, Strandbergh DR, Zak B. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem. 1983; 29: 538-42.
34. Pileggi VJ, Di Giorgio J, Wybenga DR. A one-tube serum uric acid method using phosphotungstic acid as protein precipitant and color reagents. Clin Chim Acta. 1972; 37: 141-9.
35. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18: 499-502.
36. Lohr GW, Waller HD. Glucose-6-phosphate dehydrogenase. In: Bergmeyer HU (ed.). Methods of Enzymatic Analysis. Academic Press, New York, 1967; 744-51.
37. Koul A, Singh A, Sandhir R. Effect of alpha-tocopherol on the cardiac antioxidant defense system and atherogenic lipids in cigarette smoke-inhaling mice. Inhal Toxicol. 2003; 15: 513-22.
38. Valabhji J, Elkeles RS. Dyslipidaemia in type 2 diabetes: Epidemiology and biochemistry. Br J Diabetes Vasc Dis. 2003; 3: 184-9.
39. Thomas VL, Gropper SS. Effect of chromium nicotinic acid supplementation on selected cardiovascular disease risk factors. Biol Trace Elem Res. 1996; 55: 297-305.
40. Zhang R, Yao Y, Wang Y, Ren G. Antidiabetic activity of isoquercetin in diabetic KK-Ay mice. Nutr Metab. 2011; 8: 85.
41. Shindea UA, Sharma G, Xu YJ, Dhalla NS, Goyal RK. Insulin sensitising action of chromium picolinate in various experimental models of diabetes mellitus. J Trace Elem Med Biol. 2004; 18: 23-32.
42. Lee NA, Reasner CA. Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes Care. 1994; 17: 1449-52.
43. Hao C, Hao J, Wang W et al.Insulin sensitizing effects of oligomannuronate-chromium(III) complexes in C2C12 skeletal muscle cells. PLoS ONE. 2011; 6: e24598.
44. Zhang L, Qiao Q, Tuomilehto J et al.Blood lipid levels in relation to glucose status in seven populations of Asian origin without a prior history of diabetes: The DECODA study. Diabetes Metab Res Rev. 2009; 25: 549-57.
45. Haberland ME, Fogelman AM. The role of altered lipoproteins in the pathogenesis of atherosclerosis. Am Heart J. 1987; 113: 573-7.
46. Rabinovitz H, Friedensohn A, Leibovitz A, Gabay G, Rocas C, Habot B. Effect of chromium supplementation on blood glucose and lipid levels in type 2 diabetes mellitus elderly patients. Int J Vitam Nutr Res. 2004; 74: 178-82.
47. Sharma S, Agrawal RP, Choudhary M, Jain S, Goyal S, Agarwal V. Beneficial effect of chromium supplementation on glucose, HbA1c and lipid variables in individuals with newly onset type-2 diabetes. J Trace Elem Med Biol. 2011; 25: 149-53.
48. Li F, Wu X, Zhao T et al.Anti-diabetic properties of chromium citrate complex in alloxan-induced diabetic rats. J Trace Elem Med Biol. 2011; 25: 218-24.
49. Pei D, Hsieh CH, Hung YJ, Li JC, Lee CH, Kuo SW. The influence of chromium chloride-containing milk to glycemic control of patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trial. Metabolism. 2006; 55: 923-7.
50. Wilson PW, Garrison RJ, Castelli WP, Feinleib M, McNamara PM, Kannel WB. Prevalence of coronary heart disease in the Framingham Offspring Study: Role of lipoprotein cholesterols. Am J Cardiol. 1980; 46: 649-54.
51. Cefalu WT, Wang ZQ, Zhang XH, Baldor LC, Russell JC. Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats. J Nutr. 2002; 132: 1107-14.
52. Kondeti VK, Badri KR, Maddirala DR et al.Effect of Pterocarpus santalinus bark, on blood glucose, serum lipids, plasma insulin and hepatic carbohydrate metabolic enzymes in streptozotocin-induced diabetic rats. Food Chem Toxicol. 2010; 48: 1281-7.
53. Gupta D, Raju J, Prakash J, Baquer NZ. Change in the lipid profile, lipogenic and related enzymes in the livers of experimental diabetic rats: Effect of insulin and vanadate. Diabetes Res Clin Pract. 1999; 46: 1-7.
54. Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin Invest. 2000; 106: 453-8.
55. Liu J, Bao W, Jiang M, Zhang Y, Zhang X, Liu L. Chromium, selenium, and zinc multimineral enriched yeast supplementation ameliorates diabetes symptom in streptozocin-induced mice. Biol Trace Elem Res. 2012; 146: 236-45.
56. Dentin R, Girard J, Postic C. Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): Two key regulators of glucose metabolism and lipid synthesis in liver. Biochimie. 2005; 87: 81-6.
57. Davis CM, Sumrall KH, Vincent JB. A biologically active form of chromium may activate a membrane phosphotyrosine phosphatase (PTP). Biochemistry. 1996; 35: 12.
58. Dong F, Kandadi MR, Ren J, Sreejayan N. Chromium (D-phenylalanine)3 supplementation alters glucose disposal, insulin signaling, and glucose transporter-4 membrane translocation in insulin-resistant mice. J Nutr. 2008; 138: 1846-51.
59. Anderson RA. Nutritional factors influencing the glucose/insulin system: Chromium. J Am Coll Nutr. 1997; 16: 404-10.
60. Chen WY, Chen CJ, Liu CH, Mao FC. Chromium supplementation enhances insulin signalling in skeletal muscle of obese KK/HlJ diabetic mice. Diabetes Obes Metab. 2009; 11: 293-303.
61. Martin J, Wang ZQ, Zhang XH et al.Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes. Diabetes Care. 2006; 29: 1826-32.
62. Penumathsa SV, Thirunavukkarasu M, Samuel SM et al.Niacin bound chromium treatment induces myocardial Glut-4 translocation and caveolar interaction via Akt, AMPK and eNOS phosphorylation in streptozotocin induced diabetic rats after ischemia-reperfusion injury. Biochim Biophys Acta. 2009; 1792: 39-48.
63. Wang YQ, Yao MH. Effects of chromium picolinate on glucose uptake in insulin-resistant 3T3-L1 adipocytes involve activation of p38 MAPK. J Nutr Biochem. 2009; 20: 982-91.
64. Pattar GR, Tackett L, Liu P, Elmendorf JS. Chromium picolinate positively influences the glucose transporter system via affecting cholesterol homeostasis in adipocytes cultured under hyperglycemic diabetic conditions. Mutat Res. 2006; 610: 93-100.
65. Chen G, Liu P, Pattar GR et al.Chromium activates glucose transporter 4 trafficking and enhances insulin-stimulated glucose transport in 3T3-L1 adipocytes via a cholesterol-dependent mechanism. Mol Endocrinol. 2006; 20: 857-70.
66. Rui L, Aguirre V, Kim JK et al.Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Invest. 2001; 107: 181-9.
67. Jain SK, Rains JL, Croad JL. Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-alpha, IL-6, CRP, glycated hemoglobin, triglycerides, and cholesterol levels in blood of streptozotocin-treated diabetic rats. Free Radic Biol Med. 2007; 43: 1124-31.
68. Padmavathi IJ, Rao KR, Venu L, Ismail A, Raghunath M. Maternal dietary chromium restriction programs muscle development and function in the rat offspring. Exp Biol Med. 2010; 235: 349-55.
69. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004; 89: 2548-56.
70. Madesh M, Benard O, Balasubramanian KA. Glutathione modulates lipid composition of human colon derived HT-29 cells. Int J Biochem Cell Biol. 1998; 30: 1345-52.
71. Cheng HH, Lai MH, Hou WC, Huang CL. Antioxidant effects of chromium supplementation with type 2 diabetes mellitus and euglycemic subjects. J Agric Food Chem. 2004; 52: 1385-9.